En vivo
Endpoints NewsWuXi AppTec added to Pentagon list of companies linked to Chinese militaryFierceBiotechBial bails after Parkinson’s fail, axing asset over phase 2 missClinical OMICsGenome Wide Analysis Broadens Genetic Knowledge of AnxietyFierceBiotechGSK inks $10.6B Nuvalent buyout to challenge Roche and Pfizer in lung cancerRoche MediaGSK inks $10.6B Nuvalent buyout to challenge Roche and Pfizer in lung cancer - Fierce BiotechLabiotechPharma in Spain: why global investors and innovators are moving inEndpoints NewsGSK to acquire Nuvalent and its two cancer drugs under FDA review for $10.6BeLifeExperience shapes the transformation of olfactory representations along the cortico-hippocampal pathway10x Genomics Blog10x Genomics (NASDAQ: TXG) grants 8,829 RSUs to director Suliman - Stock Titan10x Genomics Blog10x Genomics (TXG) awards 8,829 RSUs to board director - Stock Titan10x Genomics News10x Genomics (TXG) awards director Kimberly Popovits 8,829 RSUs - Stock Titan10x Genomics News10x Genomics (TXG) director receives 8,829 RSU grant, lifts holdings - Stock Titan
Endpoints News 26 nov 2025

Imfinzi's latest label expansion; FDA seeks more information on BiomX's nebulizer

Imfinzi's latest label expansion; FDA seeks more information on BiomX's nebulizer

Original
Contenido no disponible. Consulta la fuente original.